These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1673355)

  • 21. Alprazolam-neuroleptic combination in schizophrenia.
    Lipinski JF; Cohen BM
    Am J Psychiatry; 1986 Nov; 143(11):1501-2. PubMed ID: 2877587
    [No Abstract]   [Full Text] [Related]  

  • 22. Nadolol as a treatment for akathisia.
    Ratey JJ; Sorgi P; Polakoff S
    Am J Psychiatry; 1985 May; 142(5):640-2. PubMed ID: 2858984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human leukocyte antigen system in clozapine-induced agranulocytosis.
    Theodoropoulou S; Pappa H; Lykouras L; Papageorgiou G; Papasteriades C; Sakalis G
    Neuropsychobiology; 1997; 36(1):5-7. PubMed ID: 9211436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful propranolol therapy for neuroleptic-induced akathisia resistant to anticholinergic and benzodiazepine drugs.
    Hermesh H; Molcho A; Munitz H
    Clin Neuropharmacol; 1988 Aug; 11(4):369-72. PubMed ID: 2905207
    [No Abstract]   [Full Text] [Related]  

  • 25. [HLA-A, B, C antigens, Bf antigen and schizophrenia].
    Singer L; Mayer S; Tongio MM; Hauptmann G; Roos M; Danion JM; Bernard H; Leclercq P; Mandel P
    J Genet Hum; 1981 Dec; 29(5 Suppl):555-63. PubMed ID: 6979612
    [No Abstract]   [Full Text] [Related]  

  • 26. Propranolol as a primary treatment of neuroleptic-induced akathisia.
    Irwin M; Sullivan G; Van Putten T
    Hillside J Clin Psychiatry; 1988; 10(2):244-50. PubMed ID: 2906317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A controlled assessment of propranolol in the treatment of neuroleptic-induced akathisia.
    Adler L; Angrist B; Peselow E; Corwin J; Maslansky R; Rotrosen J
    Br J Psychiatry; 1986 Jul; 149():42-5. PubMed ID: 2877708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No significant association between HLA and nickel contact sensitivity.
    Silvennoinen-Kassinen S; Ilonen J; Tiilikainen A; Karvonen J
    Tissue Antigens; 1979 Nov; 14(5):459-61. PubMed ID: 12731579
    [No Abstract]   [Full Text] [Related]  

  • 29. Tardive dyskinesia and positive symptoms of schizophrenia.
    White T; Brown KW; Woods JP
    Acta Psychiatr Scand; 1991 May; 83(5):377-9. PubMed ID: 1677232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of neuroleptic-induced akathisia with propranolol: a controlled replication study.
    Kramer MS; Gorkin R; DiJohnson C
    Hillside J Clin Psychiatry; 1989; 11(2):107-19. PubMed ID: 2577308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Akathisia variants and tardive dyskinesia.
    Barnes TR; Braude WM
    Arch Gen Psychiatry; 1985 Sep; 42(9):874-8. PubMed ID: 2864031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of epidemic Kawasaki syndrome with the HLA-A2, B44, Cw5 antigen combination.
    Kaslow RA; Bailowitz A; Lin FY; Koslowe P; Simonis T; Israel E
    Arthritis Rheum; 1985 Aug; 28(8):938-40. PubMed ID: 3875353
    [No Abstract]   [Full Text] [Related]  

  • 33. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
    Barnes TR
    Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The importance of studying HLA histocompatibility antigens in eye lesions].
    Popescu MP; Vladu P
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1988; 32(4):255-9. PubMed ID: 2978083
    [No Abstract]   [Full Text] [Related]  

  • 35. Aggression, agitation, and mania with olanzapine.
    John V; Rapp M; Pies R
    Can J Psychiatry; 1998 Dec; 43(10):1054. PubMed ID: 9868577
    [No Abstract]   [Full Text] [Related]  

  • 36. Do maternal HLA antigens predispose to schizophrenia?
    Wright P; Murray RM; Donaldson PT; Underhill JA
    Lancet; 1993 Jul; 342(8863):117-8. PubMed ID: 8100884
    [No Abstract]   [Full Text] [Related]  

  • 37. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
    Goulmy E; Schipper R; Pool J; Blokland E; Falkenburg JH; Vossen J; Gratwohl A; Vogelsang GB; van Houwelingen HC; van Rood JJ
    N Engl J Med; 1996 Feb; 334(5):281-5. PubMed ID: 8532022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is schizophrenia an HLA-associated disease?
    McGuffin P
    Psychol Med; 1979 Nov; 9(4):721-8. PubMed ID: 92797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of HLA-A1, -A3, and -B15 with CMV disease in cytomegalovirus IgG-positive recipients of renal allografts.
    Harfmann P; Dittmer R; Tenschert W; Cremaschi L; Meyer-Moldenhauer WH; Arndt R; Klosterhalfen H
    Transplant Proc; 1991 Oct; 23(5):2660-1. PubMed ID: 1656569
    [No Abstract]   [Full Text] [Related]  

  • 40. Beta-adrenergic antagonists in psychosis: is improvement due to treatment of neuroleptic-induced akathisia?
    Lipinski JF; Keck PE; McElroy SL
    J Clin Psychopharmacol; 1988 Dec; 8(6):409-16. PubMed ID: 2906947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.